InvestorsHub Logo
Followers 197
Posts 24659
Boards Moderated 0
Alias Born 04/03/2010

Re: inveterate post# 483567

Tuesday, 06/07/2022 8:04:41 PM

Tuesday, June 07, 2022 8:04:41 PM

Post# of 699688
It’s a PD-1 inhibitor. Others may likely work similarly for this particular condition as well. It will be interesting to see if they do.

It’s great that this particular cancer, once it is unmasked by the drug, is so immunogenic.

The stories lack depth and are just filled with enthusiasm. Which is great. It’s a phenomenal application of just exactly the right technology to the right cancer. But Checkpoint Inhibitor (CI’s) do not do anything like that with every cancer they meet. Many will read these stories and unfortunately think there is 1 drug that melts all cancers. When really it’s a very exciting result for a very particular tumor type. Great example of how CI’s work. And hopefully the result also endures for good, and they do not get any later recurrence. Very exciting!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News